Recent Finacing
Recent Raise
Syntis Bio develops oral therapies using a SYNT polydopamine coating to transiently alter duodenal nutrient uptake, sustain gut-restricted enzymes, and increase oral drug absorption; lead programs target obesity, metabolic disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
